ViCardia Therapeutics
Phase 2Treating the underlying cause of Heart Failure Our Mission To be the Leader in Heart Failure Research & Treatment. Currently, no acute therapy for Acute Decompensated Heart Failure that is demonstrated to reduce mortality risk. Treating the underlying cause of Heart Failure. Focused on...
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Treating the underlying cause of Heart Failure Our Mission To be the Leader in Heart Failure Research & Treatment. Currently, no acute therapy for Acute Decompensated Heart Failure that is demonstrated to reduce mortality risk. Treating the underlying cause of Heart Failure. Focused on...
CardiovascularSmall Molecules